333 related articles for article (PubMed ID: 36434109)
1. Gene therapy for inborn errors of immunity: past, present and future.
Fischer A
Nat Rev Immunol; 2023 Jun; 23(6):397-408. PubMed ID: 36434109
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
Candotti F
Int J Hematol; 2014 Apr; 99(4):383-92. PubMed ID: 24488786
[TBL] [Abstract][Full Text] [Related]
4. Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.
Nishimura A; Miyamoto S; Imai K; Morio T
Int J Hematol; 2022 Jul; 116(1):7-15. PubMed ID: 35675025
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for inherited immunodeficiency.
Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
[TBL] [Abstract][Full Text] [Related]
6. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
7. Gene Therapies for Primary Immune Deficiencies.
Kohn LA; Kohn DB
Front Immunol; 2021; 12():648951. PubMed ID: 33717203
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for primary immunodeficiencies: Part 2.
Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M
Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900
[TBL] [Abstract][Full Text] [Related]
10. Progress in the field of hematopoietic stem cell-based therapies for inborn errors of immunity.
Arnold DE; Pai SY
Curr Opin Pediatr; 2023 Dec; 35(6):663-670. PubMed ID: 37732933
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy of inherited immunodeficiencies.
Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
[TBL] [Abstract][Full Text] [Related]
12. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation.
Laberko A; Mukhinа A; Machneva E; Pashchenko O; Bykova T; Vahonina L; Bronin G; Skvortsova Y; Skorobogatova E; Kondratenko I; Fechina L; Shcherbina A; Zubarovskaya L; Balashov D; Rumiantsev A
J Clin Immunol; 2023 Aug; 43(6):1241-1249. PubMed ID: 37009957
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors for the treatment of primary immunodeficiencies.
Farinelli G; Capo V; Scaramuzza S; Aiuti A
J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
16. [Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
Uchiyama T; Onodera M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):148-55. PubMed ID: 23812072
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of primary T cell immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges.
Cavazzana M; Bushman FD; Miccio A; André-Schmutz I; Six E
Nat Rev Drug Discov; 2019 Jun; 18(6):447-462. PubMed ID: 30858502
[TBL] [Abstract][Full Text] [Related]
20. Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity.
Cooper MA; Zimmerman O; Nataraj R; Wynn RF
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):628-639. PubMed ID: 33551038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
